{"schema_version":"1","generated_at":"2026-10-30T14:03:13.888Z","data_as_of":null,"url":"https://www.findmykol.com/kol/glen-lew","json_url":"https://www.findmykol.com/kol/glen-lew/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"glen-lew","name":"Glen Lew","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Atlanta","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1295799161","openalex":"A5113914703"},"summary":"Glen Lew is an Oncology physician. OpenAlex indexes 43 publications with 1,088 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":43,"cited_by_count":1088,"h_index":15,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00381680","title":"Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"Children's Oncology Group","source_url":"https://clinicaltrials.gov/study/NCT00381680","trial_url":"https://www.findmykol.com/trial/NCT00381680"}],"source":"trials"},"publications":{"total":41,"shown":5,"withheld":36,"matched_by":"OpenAlex author record","recent":[{"title":"Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase","year":2025,"journal":"Clinical Pharmacology & Therapeutics","source_url":"https://doi.org/10.1002/cpt.3616","status":"verified"},{"title":"Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial","year":2023,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(23)00314-9","status":"verified"},{"title":"The ELEMENT-MDS Trial: A Phase 3 Randomized Study Evaluating Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Non-Transfusion-Dependent, Lower-Risk Myelodysplastic Syndromes","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2023-178635","status":"verified"},{"title":"Apixaban Is Effective and Safe in Reducing Venous Thromboembolism (VTE) in Obese Patients with Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL) a Sub-Study Analysis of the Prevapix-ALL/Children's Oncology Group ACCL1333 Trial","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2023-180037","status":"verified"},{"title":"Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report","year":2022,"journal":"Cancer","source_url":"https://doi.org/10.1002/cncr.34529","status":"verified"}],"source":"works"},"contact":{"address_1":"5461 MERIDIAN MARK RD STE 400","city":"Atlanta","state":"GA","zip":"303423283","phone":"404-785-1112","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1295799161","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":36}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-06-06","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"}},"methodology_url":"https://www.findmykol.com/about#methodology"}